Soyka, L
Safety: Its important to note that while AOD-9604 demonstrated excellent safety and tolerability, the clinical development program was ultimately discontinued because efficacy for weight loss did not meet regulatory approval standards
No increase in safety events was observed
When Zepbound (Tirzepatide) is taken with insulin and the insulin dose is reduced too quickly, it can lead to high blood sugar (hyperglycemia), which increases the risk of diabetic ketoacidosis
The news release reads, in part, "This collaboration brings together Cost Plus Drugs' groundbreaking transparent pricing model and 9amHealth's high-touch, at a time where patient demand and rising medical costs have come to a head." In the TL;DR summary, this means that Cost Plus is teaming up with 9amHealth to bring cheaper obesity meds and real, expert-led care to employer health plans
Hola, hace poco me han recetado Fluoxetina en la maana